V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330013098 | 330006070 | 1.68 | null | Palliative (P) | 2016-08-23 | 2019-04-13 | UKALL14- Cons Cycle 3 | Y | N | 330011080 | BEP |
| 330013099 | 330006101 | 1.59 | null | Palliative (P) | null | 2015-03-31 | Fludarabine + Melphalan RIC Allo | null | null | 330016564 | PAC-E |
| 330013100 | 330006114 | null | 140.8 | Palliative (P) | 2018-07-14 | 2018-07-15 | EDP + MITOTANE | 02 | N | 330020339 | CAPECITABINE + CARBOPLATIN + RT |
| 330013101 | 330006144 | 1.9 | null | Adjuvant (A) | 2017-05-13 | 2017-07-04 | BLEOMYCIN + VINCRISTINE | N | N | 330024623 | CAPECITABINE + CISPLATIN |
| 330013102 | 330006155 | 1.58 | null | Palliative (P) | 2017-02-11 | 2017-09-01 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | N | 330007206 | POMALIDOMIDE |
| 330013103 | 330002938 | 0.8 | 70.7 | Palliative (P) | 2014-07-20 | 2014-07-20 | NB HRNBL-1 COJEC Ind COURSE A | N | null | 330000050 | NOT MATCHED |
| 330013105 | 330002962 | 0 | 35.9 | Curative (C) | 2018-08-08 | 2019-04-19 | NB HRNBL-1 COJEC Ind COURSE A | null | null | 330000144 | NOT MATCHED |
| 330013106 | 330002973 | null | 17.7 | Curative (C) | 2016-09-27 | 2017-08-12 | NB HRNBL-1 COJEC Ind COURSE B | N | null | 330000172 | NOT MATCHED |
| 330013107 | 330002986 | 1.75 | 12.8 | Curative (C) | 2014-07-07 | 2015-03-04 | EW EuroEwing 2012 Arm A/B Zol Acid | N | null | 330000242 | NOT MATCHED |
| 330013108 | 330003001 | 1.81 | 15 | Palliative (P) | 2018-04-27 | 2018-04-27 | NB HRNBL-1 COJEC Ind COURSE C | 02 | N | 330000299 | NOT MATCHED |
| 330013109 | 330003047 | null | 15 | Adjuvant (A) | null | 2013-09-09 | NB HRNBL-1 COJEC Ind COURSE B | 1 | null | 330000516 | NOT MATCHED |
| 330013110 | 330003053 | null | 20.1 | null | 2014-03-12 | 2014-03-16 | LCHIV | Y | null | 330000542 | NOT MATCHED |
| 330013111 | 330003111 | 0.83 | 14.8 | Palliative (P) | 2014-04-14 | 2015-03-15 | AML Interim Guidelines | 01 | N | 330000894 | NOT MATCHED |
| 330013112 | 330003302 | 1.67 | 79.45 | Adjuvant (A) | 2014-08-04 | 2014-08-31 | Cisplatin + Radiotherapy | N | null | 330002460 | CISPLATIN + RT |
| 330013113 | 330007902 | 0.88 | 86.05 | Palliative (P) | 2016-05-12 | 2016-05-15 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | N | 330004842 | NOT MATCHED |
| 330013114 | 330003553 | 1.68 | 74 | Curative (C) | 2017-07-03 | 2017-07-03 | Cisplatin + Radiotherapy | N | Y | 330004971 | CISPLATIN + RT |
| 330013115 | 330003611 | 1.23 | 12.5 | Palliative (P) | 2015-12-14 | 2015-12-24 | NB Rel CCLG guidelines Cyclo-Topotecan | N | N | 330005334 | NOT MATCHED |
| 330013116 | 330003619 | 0 | 47.3 | Curative (C) | 2016-08-06 | 2016-08-06 | NB Low/Interm risk guidelines CO | N | N | 330005388 | NOT MATCHED |
| 330013117 | 330003632 | 1.72 | null | Curative (C) | 2018-04-27 | 2018-06-08 | Cisplatin + Radiotherapy | 02 | N | 330005520 | CISPLATIN + RT |
| 330013118 | 330003646 | 1.8 | 89.25 | Curative (C) | 2016-10-23 | 2016-10-29 | Trial Unspecified | N | N | 330005587 | TRIAL |
| 330013119 | 330007964 | null | 72 | Palliative (P) | 2018-07-22 | 2018-07-22 | Mifamurtide weeks 13-36 | N | N | 330005616 | MIFAMURTIDE |
| 330013120 | 330003663 | 1.44 | 61 | Adjuvant (A) | null | 2018-03-30 | METHOTREXATE | null | null | 330005682 | METHOTREXATE |
| 330013121 | 330003742 | 1.9 | 82 | Curative (C) | 2014-05-15 | 2014-09-29 | Trial Unspecified | Y | N | 330006058 | TRIAL |
| 330013122 | 330003751 | null | 83.05 | Palliative (P) | 2014-10-01 | 2014-11-03 | EW EuroEwing 2012 Arm A VAI | null | null | 330006926 | TRIAL |
| 330013123 | 330003822 | 1.74 | 76 | Adjuvant (A) | 2015-11-15 | 2015-11-16 | Trial Unspecified | 02 | N | 330007479 | TRIAL |
| 330013124 | 330003870 | null | 74.2 | Adjuvant (A) | 2016-08-30 | 2017-11-09 | DOXORUBICIN | N | null | 330007616 | DOXORUBICIN |
| 330013125 | 330003898 | 1.71 | 66.8 | Curative (C) | 2016-09-09 | 2017-01-27 | Cisplatin 7 day | N | null | 330007724 | CISPLATIN |
| 330013126 | 330003906 | 1.85 | 70.8 | Adjuvant (A) | 2018-02-04 | 2018-03-31 | Cisplatin 7 day | 2 | N | 330007739 | CISPLATIN |
| 330013127 | 330003931 | 1.9 | null | Not known (9) | 2017-08-15 | 2017-08-16 | Cisplatin 7 day | 01 | N | 330007899 | CISPLATIN |
| 330013128 | 330003943 | 1.8 | 84.7 | Curative (C) | 2014-08-19 | 2014-10-29 | Cisplatin 7 day | N | N | 330007971 | CISPLATIN |
| 330013129 | 330012782 | 0 | 82 | Adjuvant (A) | 2017-07-07 | 2017-08-25 | Cisplatin 7 day | N | N | 330008090 | CISPLATIN |
| 330013130 | 330010436 | 1.8 | 81.9 | Palliative (P) | 2014-08-05 | 2014-08-05 | Trial Unspecified | N | N | 330008138 | TRIAL |
| 330013131 | 330004000 | 1.62 | null | Palliative (P) | 2016-05-08 | 2016-05-14 | Trial Unspecified | Y | null | 330008194 | TRIAL |
| 330013132 | 330004017 | null | 82 | Palliative (P) | 2018-01-26 | 2018-01-26 | Trial Unspecified | 02 | N | 330008235 | TRIAL |
| 330013133 | 330004028 | 1.55 | 54.4 | Not known (9) | 2017-11-05 | 2018-03-03 | Cisplatin | N | N | 330008284 | CISPLATIN |
| 330013134 | 330004119 | 1.83 | 63 | Curative (C) | 2018-04-17 | 2018-05-25 | Trial Unspecified | N | N | 330008951 | TRIAL |
| 330013135 | 330004125 | 0 | null | Palliative (P) | 2018-09-23 | 2018-10-15 | OST Euramos 1 Closed Trial - IE | 02 | N | 330008977 | TRIAL |
| 330013136 | 330011710 | 0.89 | 56.7 | Curative (C) | null | 2015-02-10 | MIFAMURTIDE | Y | null | 330009031 | MIFAMURTIDE |
| 330013138 | 330004161 | 1.61 | 82.3 | Curative (C) | null | 2017-10-23 | Methotrexate High Dose (3g/m2) | null | null | 330009184 | METHOTREXATE HIGH DOSE |
| 330013140 | 330004210 | 0 | 57.9 | Curative (C) | 2018-12-25 | 2019-03-09 | Rituximab | N | null | 330009744 | RITUXIMAB |
| 330013141 | 330004213 | 1.79 | 60.8 | Not known (9) | 2018-09-03 | 2018-09-15 | CISPLATIN + FLUOROURACIL | N | N | 330009753 | CISPLATIN + FLUOROURACIL |
| 330013142 | 330004274 | 1.7 | 62.7 | Palliative (P) | 2019-04-07 | 2019-04-07 | Etoposide + Ifosfamide (3 days) | 02 | N | 330010902 | ETOPOSIDE + IFOSFAMIDE |
| 330013143 | 330004295 | 1.76 | 89.7 | Palliative (P) | 2018-03-15 | 2018-05-05 | Carboplatin AUC 6 - 10 | N | N | 330011029 | CARBOPLATIN |
| 330013144 | 330004303 | null | 58 | Curative (C) | 2015-04-10 | 2015-06-29 | Etoposide + Ifosfamide (3 days) | 2 | N | 330011097 | ETOPOSIDE + IFOSFAMIDE |
| 330013146 | 330004344 | null | 76.2 | Curative (C) | null | 2017-03-01 | Cetuximab 7 day (>Cycle 2) | 02 | null | 330011479 | CETUXIMAB |
| 330013147 | 330011750 | 1.68 | 19.2 | Curative (C) | 2019-02-21 | 2019-07-04 | Rituximab | N | N | 330011603 | RITUXIMAB |
| 330013148 | 330008424 | 1.7 | 61 | Palliative (P) | 2018-10-23 | 2019-03-30 | CISPLATIN + FLUOROURACIL | 02 | Y | 330011981 | CISPLATIN + FLUOROURACIL |
| 330013149 | 330013044 | 1.78 | null | Palliative (P) | 2018-08-23 | 2018-08-23 | Etoposide + Ifosfamide (5 days) | N | N | 330012557 | ETOPOSIDE + IFOSFAMIDE |
| 330013150 | 330004671 | null | 61.9 | Not known (9) | 2017-07-10 | 2019-05-12 | CARBOPLATIN + PACLITAXEL | 02 | N | 330012935 | CARBOPLATIN + PACLITAXEL |
| 330013151 | 330004684 | 0 | 78.4 | Curative (C) | 2016-07-18 | 2018-12-08 | BENDAMUSTINE + RITUXIMAB | 2 | N | 330013060 | BENDAMUSTINE + RITUXIMAB |